Skip to main content

Immunome Inc.

IMNM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001472012

In the last 90 days, Immunome Inc. insiders filed 0 open-market purchases and 7 sales; 202 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Immunome Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of IMNM: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders1031114+12
Shares36.6M34.0K47.8M+11.2M (+30.6%)
Value$903.6M$838.4K$578.4M−$324.4M (−35.9%)

1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (39)

Institutions that held Immunome Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to IMNM in Q2 2024
InstitutionSharesValue% of portfolio
Opaleye Management Inc.1,102,500$13.3M3.05%
Vestal Point Capital, LP1,000,000$12.1M0.90%
Nuveen Asset Management, LLC299,290$3.62M0.00%
Adage Capital Partners GP, L.L.C.220,000$2.66M0.00%
AXA S.A.179,688$2.17M0.01%
Bank of New York Mellon Corp150,100$1.82M0.00%
Jump Financial, LLC134,300$1.63M0.03%
Rafferty Asset Management, LLC116,045$1.40M0.01%
Ensign Peak Advisors, Inc113,934$1.38M0.00%
Two Sigma Investments, LP107,846$1.30M0.00%
HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse)107,626$1.30M0.03%
SG Americas Securities, LLC90,504$1.09M0.01%
Northeast Financial Consultants Inc72,953$882.7K0.04%
Rhumbline Advisers67,184$812.9K0.00%
Prosight Management, LP65,000$786.5K0.24%
Titleist Asset Management, LLC63,967$774.0K0.12%
Alliancebernstein L.P.53,790$650.9K0.00%
Aquatic Capital Management LLC30,400$367.8K0.01%
Corebridge Financial, Inc.27,655$334.9K0.00%
Walleye Capital LLC25,457$308.0K0.00%
Profund Advisors LLC21,629$261.7K0.01%
New York State Common Retirement Fund20,800$251.7K0.00%
Voloridge Investment Management, LLC20,282$245.4K0.00%
Voya Investment Management LLC17,395$210.5K0.00%
Sequoia Financial Advisors, LLC17,065$206.5K0.00%
MetLife Investment Management13,212$159.9K0.00%
Zurcher Kantonalbank (Zurich Cantonalbank)8,011$96.9K0.00%
Quest Partners LLC6,669$80.7K0.01%
Virtus ETF Advisers LLC5,644$68.3K0.03%
Ameritas Investment Partners, Inc.5,036$60.9K0.00%
FNY Investment Advisers, LLC4,860$58.0K0.04%
Mirae Asset Global ETFs Holdings Ltd.4,369$52.3K0.00%
Citadel Advisors LLC4,167$50.4K0.00%
Amalgamated Bank1,778$22.0K0.00%
Pacer Advisors, Inc.660$7.99K0.00%
Lindbrook Capital, LLC53$6410.00%
Parallel Advisors, LLC28$3390.00%
Rothschild Investment LLC10$1210.00%
CWM, LLC10$00.00%

Sold out (27)

Institutions that held Immunome Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Not filed for Q2 2024 yet (1)

Institutions that held Immunome Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IMNM in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Credit Suisse AG33,971$838.4K